Signals Blog
Menu

Update from the Clinic: March

Welcome to your Update from the Clinic for the month of March. Undoubtedly the big news in March came from Vericel, which saw its stock double after reporting positive topline results from its Phase 2b study in heart failure. There were also some first dosings and...

Cell Therapy Deal Review: March

Welcome to your Cell Therapy Deal Review for the month of March. Cellectis continues to differentiate through a collaboration with MabQuest. PCT formed a partnership with Japanese conglomerate Hitachi. Kite partnered with Roche’s Genentech on a program for lymphoma....

Right Turn: Autism stem cell research could use a boost

While I’m sure news about autism spikes in April during the annual awareness campaign, I doubt autism is absent from the news very often. Whether parents and advocates are lobbying for more services and funding, experts and non-experts are arguing over whether...

Athletes embrace stem cell therapy, for better or worse

Randi Druzin is an author and journalist based in Toronto. She has worked at the CBC and several other major media outlets, and has written for publications such as The New York Times and The Globe and Mail. She has also written three books. Randi first learned about...